Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bergmann RN, Hope ID, Yang YJ, Watanabe RM, Meador MA, Youn JH, Ader M (1989) Assessment of insulin sensitivity in vivo: A critical review. Diab/Metab Rev 5: 411–429
Ferrannini E, Mari A (1998) How to measure insulin sensitivity. J Hypertens 16: 895–906
Goodyear LJ, Kahn BB (1998) Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 49: 235–261
Heald AH, Cruichshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A, Gibson JM (2001) Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 44: 333–339
Knowler WC, Barret-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan D (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393–403
Matsuda M, DeFronzo A (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing. Diab Care 22: 1462–1470
Matthaei S, Stumvoll M, Kellerer M, Häring HU (2000) Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 21: 585–618
Raitakari OT, Porkka KVK, Rönnemaa T, Knip M, Uhari M, Akerblom HK, Viikari JSA (1995) The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The cardiovascular risk in young Finns study. Diabetologia 38: 1042–1050
Radziuk J (2000) Insulin sensitivity and its measurement: Structural commonalities among the methods. J Clin Endocrinol Metab 85: 4426–4433
Reaven GM (2003) Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 88: 2399–2403
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Hanne-Parikka P, Keinänen-Kukaanniemi S, Laasko M, Louheranta A, Rasta M, Salminen V, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350
Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM (2000) Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diab Care 33: 171–175
Matthaei S, Stumvoll M, Kellerer M, Häring HU (2000) Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 21: 585–618
Knowler WC, Barret-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan D (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393–403
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Hanne-Parikka P, Keinänen-Kukaanniemi S, Laasko M, Louheranta A, Rasta M, Salminen V, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343–1350
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Heinze, E. (2005). Veränderungen der Insulinsensitivität und -resistenz. In: Wabitsch, M., Kiess, W., Hebebrand, J., Zwiauer, K. (eds) Adipositas bei Kindern und Jugendlichen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26775-1_18
Download citation
DOI: https://doi.org/10.1007/3-540-26775-1_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-01251-1
Online ISBN: 978-3-540-26775-1
eBook Packages: Medicine (German Language)